TNF Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
TNF Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2014 to Q2 2024.
  • TNF Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2024 was 158 %, a 68.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 158 -340 -68.2% Jun 30, 2024
Q1 2024 182 -223 -55% Mar 31, 2024
Q4 2023 305 -2.71 -0.88% Dec 31, 2023
Q3 2023 356 -106 -22.9% Sep 30, 2023
Q2 2023 499 -38.6 -7.18% Jun 30, 2023
Q1 2023 405 -278 -40.7% Mar 31, 2023
Q4 2022 308 -655 -68% Dec 31, 2022
Q3 2022 462 -254 -35.5% Sep 30, 2022
Q2 2022 537 -219 -29% Jun 30, 2022
Q1 2022 682 -83.7 -10.9% Mar 31, 2022
Q4 2021 963 +447 +86.8% Dec 31, 2021
Q3 2021 716 +40 +5.91% Sep 30, 2021
Q2 2021 757 +225 +42.3% Jun 30, 2021
Q1 2021 766 Mar 31, 2021
Q4 2020 516 Dec 31, 2020
Q3 2020 676 Sep 30, 2020
Q2 2020 532 Jun 30, 2020
Q4 2018 484 +139 +40.5% Dec 31, 2018
Q3 2018 511 +235 +85.3% Sep 30, 2018
Q2 2018 500 +208 +71.5% Jun 30, 2018
Q1 2018 435 +160 +58.4% Mar 31, 2018
Q4 2017 344 +86.1 +33.3% Dec 31, 2017
Q3 2017 276 -37.7 -12% Sep 30, 2017
Q2 2017 292 -97.9 -25.1% Jun 30, 2017
Q1 2017 275 -248 -47.5% Mar 31, 2017
Q4 2016 258 -437 -62.8% Dec 31, 2016
Q3 2016 314 -480 -60.5% Sep 30, 2016
Q2 2016 389 -562 -59% Jun 30, 2016
Q1 2016 523 -573 -52.3% Mar 31, 2016
Q4 2015 695 -519 -42.8% Dec 31, 2015
Q3 2015 794 -260 -24.7% Sep 30, 2015
Q2 2015 951 Jun 30, 2015
Q1 2015 1.1K Mar 31, 2015
Q4 2014 1.21K Dec 31, 2014
Q3 2014 1.05K Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.